NB
NBTK.XETRA Invesco NASDAQ Biotech UCITS ETF
- EUR
No recent price
- Total assets
- 640M
- Expense ratio
- 0.41%
- Dividend yield
- 0.87%
- 1-year return
- +38.35%
- Holdings
- 1
- Since
- 2014
Fund data as reported by the issuer, updated Nov 4, 2026. Total assets are in the fund's base currency.
What does NBTK.XETRA invest in?
Tracks Morningstar Gbl Biotechnology NR USD- Mostly US stocks (94.1%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (94.4%)
Asset allocation
- US stocks 94.1%
- Non-US stocks 4.7%
Invesco NASDAQ Biotech UCITS ETF performance
Sharpe ratio 1.27- This year
- +26.91%
- 1 year
- +38.35%
- 3 years
- +23.26%
- 5 years
- +7.78%
Volatility 16.0% over 1 year and 17.3% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
NBTK.XETRA price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
Invesco NASDAQ Biotech UCITS ETF top holdings
The holdings of Invesco NASDAQ Biotech UCITS ETF are not available yet.
NBTK.XETRA sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
NBTK.XETRA regional exposure
- North America94.4%
- Europe Developed2.2%
- United Kingdom1.9%
- Asia Emerging0.1%
- Australasia0.0%
- Africa/Middle East0.0%
- Asia Developed0.0%
Share of the stocks in the fund.
Company size
Average market cap 25.5B- Mega cap0.6%
- Big cap25.6%
- Medium cap33.5%
- Small cap25.5%
- Micro cap11.9%
Invesco NASDAQ Biotech UCITS ETF fund profile
- Fund name
- Invesco NASDAQ Biotech UCITS ETF
- Ticker
- NBTK.XETRA
- Exchange
- XETRA Stock Exchange
- Index tracked
- Morningstar Gbl Biotechnology NR USD
- Category
- Healthcare Equity
- Domicile
- Ireland
- Inception date
- Nov 6, 2014
- Trading currency
- EUR
- Expense ratio
- 0.41%